You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Retinal Drugs and Biologics Market Research Report 2021 Professional Edition

Market Analysis and Insights: Global Retinal Drugs and Biologics Market
The global Retinal Drugs and Biologics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Retinal Drugs and Biologics Scope and Segment
The global Retinal Drugs and Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Drugs and Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
By the end users/application, this report covers the following segments
Hospitals
Clinics
Others
Competitive Landscape:
The report provides a list of all the key players in the Retinal Drugs and Biologics market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Retinal Drugs and Biologics key manufacturers in this market include:
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares
1 Retinal Drugs and Biologics Market Overview
1.1 Retinal Drugs and Biologics Product Overview
1.2 Retinal Drugs and Biologics Market Segment by Type
1.2.1 Age Related Macular Degeneration
1.2.2 Diabetic Retinopathy
1.2.3 Ocular Inflammatory Disease (Uveitis)
1.2.4 Macular Hole
1.3 Global Retinal Drugs and Biologics Market Size by Type
1.3.1 Global Retinal Drugs and Biologics Market Size Overview by Type (2016-2027)
1.3.2 Global Retinal Drugs and Biologics Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Retinal Drugs and Biologics Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Retinal Drugs and Biologics Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Retinal Drugs and Biologics Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Retinal Drugs and Biologics Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Retinal Drugs and Biologics Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Retinal Drugs and Biologics Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Retinal Drugs and Biologics Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Retinal Drugs and Biologics Sales Breakdown by Type (2016-2021)
1.4.2 Europe Retinal Drugs and Biologics Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Retinal Drugs and Biologics Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Retinal Drugs and Biologics Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Retinal Drugs and Biologics Sales Breakdown by Type (2016-2021)

2 Global Retinal Drugs and Biologics Market Competition by Company
2.1 Global Top Players by Retinal Drugs and Biologics Sales (2016-2021)
2.2 Global Top Players by Retinal Drugs and Biologics Revenue (2016-2021)
2.3 Global Top Players Retinal Drugs and Biologics Price (2016-2021)
2.4 Global Top Manufacturers Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.5.1 Retinal Drugs and Biologics Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Retinal Drugs and Biologics Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Retinal Drugs and Biologics as of 2020)
2.7 Date of Key Manufacturers Enter into Retinal Drugs and Biologics Market
2.8 Key Manufacturers Retinal Drugs and Biologics Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Retinal Drugs and Biologics Status and Outlook by Region
3.1 Global Retinal Drugs and Biologics Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Retinal Drugs and Biologics Historic Market Size by Region
3.2.1 Global Retinal Drugs and Biologics Sales in Volume by Region (2016-2021)
3.2.2 Global Retinal Drugs and Biologics Sales in Value by Region (2016-2021)
3.2.3 Global Retinal Drugs and Biologics Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Retinal Drugs and Biologics Forecasted Market Size by Region
3.3.1 Global Retinal Drugs and Biologics Sales in Volume by Region (2022-2027)
3.3.2 Global Retinal Drugs and Biologics Sales in Value by Region (2022-2027)
3.3.3 Global Retinal Drugs and Biologics Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Retinal Drugs and Biologics by Application
4.1 Retinal Drugs and Biologics Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Retinal Drugs and Biologics Market Size by Application
4.2.1 Global Retinal Drugs and Biologics Market Size Overview by Application (2016-2027)
4.2.2 Global Retinal Drugs and Biologics Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Retinal Drugs and Biologics Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Retinal Drugs and Biologics Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Retinal Drugs and Biologics Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Retinal Drugs and Biologics Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Retinal Drugs and Biologics Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Retinal Drugs and Biologics Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Retinal Drugs and Biologics Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Retinal Drugs and Biologics Sales Breakdown by Application (2016-2021)
4.3.2 Europe Retinal Drugs and Biologics Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Retinal Drugs and Biologics Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Retinal Drugs and Biologics Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Retinal Drugs and Biologics Sales Breakdown by Application (2016-2021)

5 North America Retinal Drugs and Biologics by Country
5.1 North America Retinal Drugs and Biologics Historic Market Size by Country
5.1.1 North America Retinal Drugs and Biologics Sales in Volume by Country (2016-2021)
5.1.2 North America Retinal Drugs and Biologics Sales in Value by Country (2016-2021)
5.2 North America Retinal Drugs and Biologics Forecasted Market Size by Country
5.2.1 North America Retinal Drugs and Biologics Sales in Volume by Country (2022-2027)
5.2.2 North America Retinal Drugs and Biologics Sales in Value by Country (2022-2027)

6 Europe Retinal Drugs and Biologics by Country
6.1 Europe Retinal Drugs and Biologics Historic Market Size by Country
6.1.1 Europe Retinal Drugs and Biologics Sales in Volume by Country (2016-2021)
6.1.2 Europe Retinal Drugs and Biologics Sales in Value by Country (2016-2021)
6.2 Europe Retinal Drugs and Biologics Forecasted Market Size by Country
6.2.1 Europe Retinal Drugs and Biologics Sales in Volume by Country (2022-2027)
6.2.2 Europe Retinal Drugs and Biologics Sales in Value by Country (2022-2027)

7 Asia-Pacific Retinal Drugs and Biologics by Region
7.1 Asia-Pacific Retinal Drugs and Biologics Historic Market Size by Region
7.1.1 Asia-Pacific Retinal Drugs and Biologics Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Retinal Drugs and Biologics Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Retinal Drugs and Biologics Forecasted Market Size by Region
7.2.1 Asia-Pacific Retinal Drugs and Biologics Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Retinal Drugs and Biologics Sales in Value by Region (2022-2027)

8 Latin America Retinal Drugs and Biologics by Country
8.1 Latin America Retinal Drugs and Biologics Historic Market Size by Country
8.1.1 Latin America Retinal Drugs and Biologics Sales in Volume by Country (2016-2021)
8.1.2 Latin America Retinal Drugs and Biologics Sales in Value by Country (2016-2021)
8.2 Latin America Retinal Drugs and Biologics Forecasted Market Size by Country
8.2.1 Latin America Retinal Drugs and Biologics Sales in Volume by Country (2022-2027)
8.2.2 Latin America Retinal Drugs and Biologics Sales in Value by Country (2022-2027)

9 Middle East and Africa Retinal Drugs and Biologics by Country
9.1 Middle East and Africa Retinal Drugs and Biologics Historic Market Size by Country
9.1.1 Middle East and Africa Retinal Drugs and Biologics Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Retinal Drugs and Biologics Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Retinal Drugs and Biologics Forecasted Market Size by Country
9.2.1 Middle East and Africa Retinal Drugs and Biologics Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Retinal Drugs and Biologics Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Retinal Drugs and Biologics Business
10.1 ALLERGAN
10.1.1 ALLERGAN Corporation Information
10.1.2 ALLERGAN Introduction and Business Overview
10.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.1.4 ALLERGAN Retinal Drugs and Biologics Products Offered
10.1.5 ALLERGAN Recent Development
10.2 AbbVie
10.2.1 AbbVie Corporation Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.2.4 ALLERGAN Retinal Drugs and Biologics Products Offered
10.2.5 AbbVie Recent Development
10.3 Alimera Sciences
10.3.1 Alimera Sciences Corporation Information
10.3.2 Alimera Sciences Introduction and Business Overview
10.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Alimera Sciences Retinal Drugs and Biologics Products Offered
10.3.5 Alimera Sciences Recent Development
10.4 Janssen Biotech
10.4.1 Janssen Biotech Corporation Information
10.4.2 Janssen Biotech Introduction and Business Overview
10.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Janssen Biotech Retinal Drugs and Biologics Products Offered
10.4.5 Janssen Biotech Recent Development
10.5 Swedish Orphan Biovitrum
10.5.1 Swedish Orphan Biovitrum Corporation Information
10.5.2 Swedish Orphan Biovitrum Introduction and Business Overview
10.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Products Offered
10.5.5 Swedish Orphan Biovitrum Recent Development
10.6 Roche
10.6.1 Roche Corporation Information
10.6.2 Roche Introduction and Business Overview
10.6.3 Roche Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Roche Retinal Drugs and Biologics Products Offered
10.6.5 Roche Recent Development
10.7 Bristol-Myers Squibb
10.7.1 Bristol-Myers Squibb Corporation Information
10.7.2 Bristol-Myers Squibb Introduction and Business Overview
10.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Products Offered
10.7.5 Bristol-Myers Squibb Recent Development
10.8 Genzyme
10.8.1 Genzyme Corporation Information
10.8.2 Genzyme Introduction and Business Overview
10.8.3 Genzyme Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Genzyme Retinal Drugs and Biologics Products Offered
10.8.5 Genzyme Recent Development
10.9 Genentech
10.9.1 Genentech Corporation Information
10.9.2 Genentech Introduction and Business Overview
10.9.3 Genentech Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Genentech Retinal Drugs and Biologics Products Offered
10.9.5 Genentech Recent Development
10.10 OCULAR THERAPEUTIX
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
10.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 OCULAR THERAPEUTIX Recent Development
10.11 Bausch & Lomb
10.11.1 Bausch & Lomb Corporation Information
10.11.2 Bausch & Lomb Introduction and Business Overview
10.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Bausch & Lomb Retinal Drugs and Biologics Products Offered
10.11.5 Bausch & Lomb Recent Development
10.12 UCBCares
10.12.1 UCBCares Corporation Information
10.12.2 UCBCares Introduction and Business Overview
10.12.3 UCBCares Retinal Drugs and Biologics Sales, Revenue and Gross Margin (2016-2021)
10.12.4 UCBCares Retinal Drugs and Biologics Products Offered
10.12.5 UCBCares Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Retinal Drugs and Biologics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Retinal Drugs and Biologics Industrial Chain Analysis
11.4 Retinal Drugs and Biologics Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Retinal Drugs and Biologics Distributors
12.3 Retinal Drugs and Biologics Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140